Founder, President & CEO

How to navigate the whisky cask boom

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer

Braeburn gets FDA approval for opioid use disorder drug after more than 4-year battle

FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder

Regional Business Specialist

Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder. The Regional Business Specialist is responsible for identifying, creating, and implementing opportunities within key accounts in the criminal justice and federal systems while ensuring access for appropriate patients.

Sign up with Google

Sign in with Google